跳至主要内容
临床试验/NCT05791656
NCT05791656招募中不适用

Composite Interference Screw in the Surgical Reconstruction of Knee Cruciate Ligaments: a Prospective Observational Study

Medacta International SA1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2023年3月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
44
试验地点
1
主要终点
Interference screw presence

研究概览

简要总结

An observational prospective study with the aim to analyze the presence at 6 months of a specific composite IS (Medacta Mectascrew C) in the reconstructive treatment of ruptured ACL or PCL by means of an autograft or allograft.

详细描述

This is an observational prospective study with the aim to determine the presence of the composite IS (Mectascrew-C) at 6 months following ACL or PCL reconstruction.

Patients with an ACL or PCL tear scheduled for surgery at one of the EOC's hospitals will be enrolled in the study, after the subscription of informed consent. The injured ligament will be restored with an auto- or allograft that will be fixed with a composite IS (Mectascrew-C, 70% PLDLLA, 30% β-TCP, Medacta International SA).

The data will be collected from patient's medical histories (data about diagnosis, patients' characteristics and surgery) and after operation, during the orthopaedic follow-up visits, planned at 1, 3 and 6 months, in order to assess the functional outcomes (IKDC objective and subjective) and the knee stability (ROM, Pivot Shift or Reverse Pivot Shift test, anterior or posterior drawer test) of the patients.

The treated knee will be also evaluated radiologically with an MRI at 6 months to assess the IS reabsorption. The results of this exam will be correlated to the pre-operative findings and to the functional and clinical outcomes evaluated with the different forms

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of both sexes aged 16-60 yrs
  • Pre-operative MRI confirming the ACL or PCL rupture
  • Scheduled for surgical reconstruction of ACL or PCL
  • BMI>18 and <35 kg/m2
  • Ability to give informed consent by signature

排除标准

  • Age under 16 or over 60 yrs
  • Degenerative osteopathies
  • Local bone tumors
  • Deformities of the bone, or general conditions of the bone, which preclude the implantation in the opinion of a physician
  • Systemic diseases and metabolic disorders that may compromise the outcome of the surgery

结局指标

主要结局

Interference screw presence

时间窗: 6 months

via MRI imaging at 6 months after surgery, the presence of the Mectascrew-C will be assessed

次要结局

  • Functional outcomes evaluation(1, 3 and 6 months)
  • Mobility outcomes evaluation(1, 3 and 6 months)
  • ACL integrity assessment(1, 3 and 6 months)
  • Knee stability evaluation of PCL intervention(1, 3 and 6 months)
  • Device safety evaluation(1, 3 and 6 months)
  • Knee stability evaluation of ACL intervention(1, 3 and 6 months)
  • PCL integrity assessment(1, 3 and 6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验